Biogen Inc. Equity-NMS: BIIB

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$130.71
Open :$129.22
Today's high :$129.95
Today's low :$122.77
52W low :$122.77
52W high :$238
EPS(TTM): :11.18
Shares O/S :146.38 M
Market cap :18 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Biogen Inc. $122.98 -7.81% 11.69 18.00B

Frequently Asked Questions

What is the share price of Biogen Inc. today?

Biogen Inc. (BIIB) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Biogen Inc.

Biogen Inc. is a global biopharmaceutical company. The Company is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. It also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).